share_log

Reflect Scientific Inc Reports First Quarter 2023 Results

Reflect Scientific Inc Reports First Quarter 2023 Results

Reflect Scientific Inc 公佈
GlobeNewswire ·  2023/05/12 20:00

OREM, Utah, May 12, 2023 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (OTCQB: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries today reported financial results for the first quarter ended March 31, 2023. Revenues decreased by $512,449, or 68.0%, to $241,127 for the three months ended March 31, 2023 from $753,576 for the three months ended March 31, 2022. The decrease was primarily due to a significant reduction in freezer and chiller sales and ongoing supply chain delays with manufacturers.

猶他州奧雷姆,2023年5月12日(Global Newswire)--Reflect Science,Inc.(場外交易市場代碼:RSCF)是一家為生物技術、製藥和運輸行業提供多種產品和服務的公司,今天公佈了截至2023年3月31日的第一季度財務業績。在截至2023年3月31日的三個月中,收入下降了512,449美元,降幅為68.0%,從截至2022年3月31日的三個月的753,576美元降至241,127美元。減少的主要原因是冷凍機和冷凍機的銷售大幅減少,以及與製造商的供應鏈持續延誤。

Reflect Scientific has been able to manage its expenses effectively, with salaries and wages decreasing by $8,004, or 4.7%, to $162,275 for the three months ended March 31, 2023 from $170,279 for the three months ended March 31, 2022. General and administrative expenses decreased by $10,186, or 8.7%, to $106,992 for the three months ended March 31, 2023 from $117,178 for the three months ended March 31, 2022. Research and development expenses decreased by $19,259, or 76.0%, to $6,066 for the three months ended March 31, 2023 from $25,325 for the three months ended March 31, 2022.

Reflect Science一直能夠有效地管理開支,截至2023年3月31日的三個月,工資和工資從截至2022年3月31日的170,279美元下降到162,275美元,降幅為8,004美元,降幅為4.7%。截至2023年3月31日的三個月,一般和行政費用減少了10,186美元,降幅為8.7%,從截至2022年3月31日的三個月的117,178美元降至106,992美元。截至2023年3月31日的三個月,研究和開發費用減少了19,259美元,降幅為76.0%,從截至2022年3月31日的三個月的25,325美元降至6,066美元。

Reflect Scientific's current assets exceeded current liabilities by $2,052,802 and $2,179,237 as of March 31, 2023 and December 31, 2022, respectively, and the Company had cash and cash equivalents of $1,199,069 and $1,381,927, respectively.

截至2023年3月31日和2022年12月31日,Reflect Science的流動資產比流動負債分別高出2,052,802美元和2,179,237美元,公司的現金和現金等價物分別為1,199,069美元和1,381,927美元。

Reflect Scientific's CEO, Mr. Kim Boyce, commented, "We faced some significant challenges in the first quarter, including ongoing supply chain delays and decreased sales, particularly in our freezer and chiller product lines. However, we remain committed to our goal of providing our customers with the best solution for their needs and we continue to focus on expanding our product portfolio to align with and capitalize on market needs. To that end, Reflect is collaborating with a company to explore new applications for the chiller products. We are optimistic about the future and are confident that our ongoing efforts to increase sales, improve gross margins, and control ongoing operating expenses will yield positive results."

Reflect Science首席執行官Mr.Kim·博伊斯表示:“我們在第一季度面臨一些重大挑戰,包括供應鏈持續延遲和銷售額下降,特別是在我們的冷凍機和冷凍機產品線上。然而,我們仍然致力於為我們的客戶提供滿足他們需求的最佳解決方案的目標,並繼續專注於擴大我們的產品組合,以符合市場需求並利用市場需求。為此,Reflect正在與一家公司合作,探索冷風機產品的新應用。我們對未來持樂觀態度,並相信我們為增加銷售額、提高毛利率和控制持續運營費用所做的持續努力將產生積極的結果。“

About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific's products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn .

Reflect Science公司簡介
總部設在猶他州奧雷姆的Reflect Science,Inc.為生物技術、製藥、醫療和運輸市場開發和營銷低溫冷卻領域的創新專有技術。Reflect Science的產品包括用於實驗室、運輸和電腦服務器機房的低溫冷凍機和製冷系統。有關更多資訊,請訪問ReflectScience fic.com。在Twitter@ReflectSci和LinkedIn上查看我們。

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol "RSCF" and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading "Disclosure," including those identified in such filings as "forward-looking statements."

前瞻性陳述
本新聞稿包含符合修訂後的1933年證券法第27A節和修訂後的1934年證券交易法第21E節的前瞻性陳述。前瞻性陳述不是對未來業績或結果的保證,也不一定準確地說明實現業績或結果的時間或方式。前瞻性陳述以作出陳述時可獲得的資訊為基礎,涉及已知和未知的風險、不確定因素和其他因素,這些風險、不確定性和其他因素可能會導致我們的結果、活動水準、業績或成就與本新聞稿中前瞻性陳述明示或暗示的資訊大不相同。考慮本新聞稿時,應參考場外交易市場集團LLC以“RSCF”為交易代碼提交的公司檔案中所包含的披露,以及其中引用幷包含在證券交易委員會埃德加檔案“披露”標題下的公司先前的相關檔案,包括在此類檔案中標識為“前瞻性陳述”的那些檔案。

CONTACT: Contact Thomas Tait 801-607-1039 investor_relations@reflectscientific.com
聯繫人:Contact:Contact:Thomas Tait電話:801-607-1039

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論